Christopher Haqq
Chief Tech/Sci/R&D Officer en ELICIO THERAPEUTICS, INC. .
Fortuna: - $ al 29/02/2024
Perfil
Christopher M.
Haqq holds the position of Chief Medical Officer, EVP & Head-Research at Elicio Therapeutics, Inc. and Chief Medical Officer & Executive Vice President at Elicio Therapeutics, Inc. (Old) (a subsidiary of Elicio Therapeutics, Inc.).
In the past he held the position of Vice President-Clinical Research & Development at Janssen Oncology, Inc. and Vice President-Clinical Research & Development at Cougar Biotechnology, Inc. (a subsidiary of Janssen Oncology, Inc.), Chief Scientific Officer, Executive VP-R&D at Atara Biotherapeutics, Inc., Manager-Early Development Oncology Group at Amgen, Inc. and Assistant Professor at The University of California, San Francisco.
Dr. Haqq received a doctorate from Harvard Medical School and an undergraduate degree from Stanford University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
ELICIO THERAPEUTICS, INC
-.--% | 01/02/2024 | 0 ( -.--% ) | - $ | 29/02/2024 |
Cargos activos de Christopher Haqq
Empresas | Cargo | Inicio |
---|---|---|
ELICIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2019 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/10/2019 |
Antiguos cargos conocidos de Christopher Haqq.
Empresas | Cargo | Fin |
---|---|---|
ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 25/10/2019 |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Chief Tech/Sci/R&D Officer | 01/09/2011 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Chief Tech/Sci/R&D Officer | 13/07/2009 |
SURROZEN, INC. | Director/Board Member | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
Formación de Christopher Haqq.
Stanford University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
AMGEN INC. | Health Technology |
ELICIO THERAPEUTICS, INC. | Health Technology |
ATARA BIOTHERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
Consonance-HFW Acquisition Corp.
Consonance-HFW Acquisition Corp. Financial ConglomeratesFinance Consonance-HFW Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisitions, share purchase, reorganization, or similar business combination. The company was founded by Gad Soffer and Kevin Harold Livingston on August 21, 2020 and is headquartered in Princeton, NJ. | Finance |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |